BTAIVSJBIO• 3 Months (Normalized)
BTAI vs JBIO (BioXcel Therapeutics Inc. vs Jade Biosciences Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-95.6%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
JBIO Performance $17.89
+11.12%
Jade Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin JBIO LEADS
-106.72%
JBIO outperforming by 106.72%
BTAIJBIO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI JBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | JBIO Price | JBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -95.60% | $17.89 | +11.12% | -106.72% |
| Sep 10, 2026 | $0.05 | -95.69% | $19.14 | +18.88% | -114.57% |
| Sep 09, 2026 | $0.05 | -95.95% | $19.06 | +18.39% | -114.34% |
| Sep 08, 2026 | $0.04 | -96.29% | $19.45 | +20.81% | -117.10% |
| Sep 04, 2026 | $0.07 | -93.63% | $19.90 | +23.60% | -117.23% |
| Sep 03, 2026 | $0.12 | -89.83% | $19.85 | +23.29% | -113.12% |
| Sep 02, 2026 | $0.11 | -90.78% | $21.40 | +32.92% | -123.70% |
| Sep 01, 2026 | $0.14 | -88.19% | $21.02 | +30.56% | -118.75% |
| Aug 31, 2026 | $0.16 | -85.95% | $21.36 | +32.67% | -118.62% |
| Aug 28, 2026 | $0.18 | -84.40% | $20.84 | +29.44% | -113.84% |
| Aug 27, 2026 | $0.72 | -38.02% | $21.29 | +32.24% | -70.26% |
| Aug 26, 2026 | $0.78 | -32.76% | $21.33 | +32.48% | -65.24% |
| Aug 25, 2026 | $0.74 | -36.03% | $21.84 | +35.65% | -71.68% |
| Aug 24, 2026 | $0.76 | -34.40% | $21.33 | +32.48% | -66.88% |
| Aug 21, 2026 | $0.80 | -30.69% | $21.34 | +32.55% | -63.24% |
Page 1 of 5